|
|
Post by careful2invest on Apr 6, 2017 16:10:54 GMT -5
Why don't all of you just double down, now that it is so cheap? What, you don't believe in the company anymore? You can come out of it as a complete genius, or a total fool... The struggle between greed and fear... I personally cannot pull that trigger...At least for now. |
|
|
|
Post by sluggobear on Apr 6, 2017 16:43:09 GMT -5
I'm in 7 years now. At least 5 separate purchases over that time. I'm down $280k, more than 90% - a huge loss on paper for me. To make matters worse I transferred all of the stock (IRA) into a Roth and paid the significant tax penalty to do so. I'll not be able to write off one dime! Nobody has been a stronger believer than me. But at this point I see no happy ending for any of us except for the guys running the show pulling down 7 figure salaries. Hell, if I had a 7 figure contract I'd probably be doing the exact same thing. The company simply cannot seem to make Afrezza work for the larger Diabetic Community. Whatever the reason, take your pick, it makes me sick. For 7 years I've patiently and enthusiastically bought all of the BS Matt, and now Mike, have spooned out to shareholders. I no longer believe one word of management's excuses and Pollyanna prognostications. Yep, we're on the way, right around the corner. I deleted Yahoo Finance MNKD board three years ago. I only check in here once a week now. My stomach can't take the stress of daily updates, forum rants and silly guessing games. I've lost so much by now that there's no point in selling so I guess I'm in to the bitter end. And, man, is it bitter! Sorry for the downer post. Hope some of you have a better outlook. I guess there is some solace in that so many of us are in the same boat. I've never made such a stupid large investment/gamble ever. I also have a Ph.D in biology and have managed biotech firms, public though. But I've been across the table from many, many startups with technology that made little sense at the time but then got bought up for ridiculous amounts of money. It seemed like a no-brainer but of course execution is Paramount. I should have sold when Al Mann turned over leadership. Since then, and I know many here agree, the needed skills, competency, and visionary understanding of how to break into this Market have not been there. I believed that insurance and pricing would be major barriers BECAUSE Afrezza is such a disruptive new product. This is not a slow sinking of the ship; it's going down quickly. There may be no way to bail it out now but I will say once again if they drop the price low enough to eliminate insurance in the equation they may pull enough diabetics in to get the RX number rolling. Revenues at this point are meaningless. |
|
|
|
Post by sportsrancho on Apr 6, 2017 17:25:03 GMT -5
I did the IRA to Roth conversion on the first trading day of 2016, just before SNY dumped us. I lost almost 50% in one day and tried to get Fidelity to cancel the transaction but they couldn't. They exlained that I would be able to recharacterize (reverse) the move later in the year if I wanted but suggested that I wait to see if the stock would recover to the price I converted at ($1.46 pre R/S) before doing anything. The stock did move back up to over $2 so I thought I made the right move and hung in there. By the end of the year the stock was far below $1.46 so I recharacterized rather than pay the tax to convert. But I really didn't understand the tax laws. Fidelity took all of the stock I held in my Roth to satisfy the recharacterization requirements (total $ value has to be returned) and I was still short about $15k. So now I still have to pay ordinary income tax on the $15k and all of the shares (non MNKD) that were held in my tax free Roth are now in my taxable IRA. Pretty dumb move on my part. That really sucks:-( I've always had shares in my Roth. Never converted them. I think there's about 3,000 in there now. But in another account I had a large amount from selling my house. When the TASE fiasco happened someone that I trusted called and said SELL. I sold it all. Then when it turned out to be a false alarm I jumped back in but only with half because I just wasn't sure what was going on. I bought WYNN then with most of the other half and some calls on MNKD that died in Jan. Thank god I have WYNN because it's helping me make back part of the loss. If scripts are up tomorrow I will buy some 1.50 2018 calls in case of a cheap buy out. I was waiting for$1.25 to buy the calls and was tied up all day and didn't put the trigger. Biggest loss ever for me too though..But as everyone knows I have not given up on Mike turning this around:-) |
|
|
|
Post by mnkdfann on Apr 6, 2017 17:38:49 GMT -5
Why don't all of you just double down, now that it is so cheap? At least as a short term trade that may not be a bad move. Last year MNKD was 1.22 on April 8 and then jumped to nearly 2.00 a week or two later. A similar bounce this year would not surprise me at all. |
|
|
|
Post by mytakeonit on Apr 6, 2017 17:51:02 GMT -5
Why don't all of you just double down, now that it is so cheap? At least as a short term trade that may not be a bad move. Last year MNKD was 1.22 on April 8 and then jumped to nearly 2.00 a week or two later. A similar bounce this year would not surprise me at all. This year it'll be on April 7th ... on Big Hair script day! And Sports ... you're welcome. I stay at the Wynn/Encore every time I visit Las Vegas and try to build that stock up. With great success ... I'm sad to mention. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 6, 2017 17:52:04 GMT -5
I did the IRA to Roth conversion on the first trading day of 2016, just before SNY dumped us. I lost almost 50% in one day and tried to get Fidelity to cancel the transaction but they couldn't. They exlained that I would be able to recharacterize (reverse) the move later in the year if I wanted but suggested that I wait to see if the stock would recover to the price I converted at ($1.46 pre R/S) before doing anything. The stock did move back up to over $2 so I thought I made the right move and hung in there. By the end of the year the stock was far below $1.46 so I recharacterized rather than pay the tax to convert. But I really didn't understand the tax laws. Fidelity took all of the stock I held in my Roth to satisfy the recharacterization requirements (total $ value has to be returned) and I was still short about $15k. So now I still have to pay ordinary income tax on the $15k and all of the shares (non MNKD) that were held in my tax free Roth are now in my taxable IRA. Pretty dumb move on my part. That really sucks:-( I've always had shares in my Roth. Never converted them. I think there's about 3,000 in there now. But in another account I had a large amount from selling my house. When the TASE fiasco happened someone that I trusted called and said SELL. I sold it all. Then when it turned out to be a false alarm I jumped back in but only with half because I just wasn't sure what was going on. I bought WYNN then with most of the other half and some calls on MNKD that died in Jan. Thank god I have WYNN because it's helping me make back part of the loss. If scripts are up tomorrow I will buy some 1.50 2018 calls in case of a cheap buy out. I was waiting for$1.25 to buy the calls and was tied up all day and didn't put the trigger. Biggest loss ever for me too though..But as everyone knows I have not given up on Mike turning this around:-) I was going to look at some calls for the next few months. Play a squeeze if there is some script weeks that drive the price up for a short peroid of time. I am sure they are cheap |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 6, 2017 17:54:54 GMT -5
Why don't all of you just double down, now that it is so cheap? At least as a short term trade that may not be a bad move. Last year MNKD was 1.22 on April 8 and then jumped to nearly 2.00 a week or two later. A similar bounce this year would not surprise me at all. Those bounces happened when the interest on borrowing shares was sky high. That factor is the reason there have been non event squeezes like we used to see. |
|
|
|
Post by gamblerjag on Apr 6, 2017 18:37:14 GMT -5
Why don't all of you just double down, now that it is so cheap? At least as a short term trade that may not be a bad move. Last year MNKD was 1.22 on April 8 and then jumped to nearly 2.00 a week or two later. A similar bounce this year would not surprise me at all. . Which would now be $10 |
|
Tinkerbell
Researcher
Watcher of the Skies
Posts: 143
|
Post by Tinkerbell on Apr 6, 2017 20:24:59 GMT -5
For what it's worth, the manipulation we're seeing on the share price post-split is not a new phenomenon. In fact, it's par for the course. The volatile pounding of a company's stock post split is absolute in its intent to shatter the little confidence some long term investors may have (which by the way includes large retail houses). As far as I know, there has been no 'new' negative development that's been announced since the 10K was filed, nor for that matter, since the CC on March 16th - just 16 days ago. What then is causing such activity against the stock price? I don't think this needs any explanation because we all know precisely what is a work here.
Mike clearly warned investors 16 days ago that investors should be realistic and not expect any significant spike in prescription numbers for several weeks. In my view, and as far as I'm concerned, that means well into May and please let's not get into a discussion on what the term 'several' means.
In addition, the financials and strategy for 2017 were in line with expectations and as I recall more than one analyst and several investors commented on the on progress to date with guarded optimism. Was there lingering trepidation around the company's finances? Yes. That said however, the BOD, CEO and CFO are well aware of upcoming financial obligations and we must trust they are working to fulfill their fiduciary responsibility to all shareholders on this front.
Interestingly, since the split, some investors (not here necessarily) speculate that perhaps the split was not the right course rather an extension on the NASDAQ listing should have been pursued. It appears to me that this was not an option. Internal rules which govern such decisions at the exchange may have precluded MannKind from such. Does anyone doubt that if an extension could have been granted, the Board would not have pursued it rather than a reverse split? There is little doubt in my mind though I have NO definitive proof to back up this statement.
Some investors have said delisting might have been a better path to take which I ignore completely because clearly these investors forget that MannKind had just hired its own sales force and to delist would have been far more destructive to Mike's re-launch efforts that one can possibly imagine. All employees at MannKind knew full well what a reverse split might do to the value of any options they held. I'm certain they are no more surprized than I am that their value has gone down considerably.
What I believe is MannKind's sales reps have fanned out across the country to begin the thankless and laborious task of effecting an unthinkable paradigmn shift, one by one, MD by MD, patient by patient, script by script all the while having to repeatedly dispell half truths left by the sales rep before them. Thankfully thus far I've not seen an exodus of sale reps showing up on the Mannkind's or other Pharma/Biotech jobs boards. They are out there and that's what counts.
I think the sales plan and DTC is on track to make the difference Mike has stated we'll see in summer. I am willing to wager my last dollar that by the end of August, the gloom we may be feeling today will be replaced with better spirits. That said, I still ask myself every day despite the erosion of in the value of my investment: 'Am I willing to weather this storm for yet another turbulent day with the same belief and conviction I had when I first learned of Afrezza, what amazing relief it could provide to diabetics and took the leap of faith to invest in the company who developed it?' My answer is always a resounding YES - it most definitely is worth it to me. So I keep my chin up like the proverbial Englishman with bulldog in tow and carry on to the next day.
|
|
|
|
Post by sportsrancho on Apr 6, 2017 20:39:43 GMT -5
Tinker, no one says it better than you do!!
|
|
|
|
Post by fanz8967 on Apr 6, 2017 22:05:33 GMT -5
Why don't all of you just double down, now that it is so cheap? What, you don't believe in the company anymore? You can come out of it as a complete genius, or a total fool... The struggle between greed and fear... I personally cannot pull that trigger...At least for now. I mean if the shares cost 167,000 and now they are 10,000, you can buy the same amount of shares for another 10,000. If all goes well you'll have 167,000 back halfway from where you bought them, originally. How many shares are there even to buy? 96 million total, not counting those held by the Al Mann Foundation and officers of the company? What is left like 50 million? I mean, you only need about 5000 people to buy 10,000 shares each and then there are no shares left. Then surely the shorts would have to cover. I would think if you guys believe in this company you would just buy them all up. I'll tell you what. If script numbers are good tomorrow I'll buy 10,000 shares. Someone told me that they need to get over 300 total scripts. That sounds awfully low to me, but if they get 300 scripts I'll buy 10,000 shares. Then, maybe, I'll buy another 10,000 every time the scripts go up 100. That should help you guys, right? Who's with me? |
|
|
|
Post by straightly on Apr 6, 2017 22:10:48 GMT -5
You can come out of it as a complete genius, or a total fool... The struggle between greed and fear... I personally cannot pull that trigger...At least for now. I mean if the shares cost 167,000 and now they are 10,000, you can buy the same amount of shares for another 10,000. If all goes well you'll have 167,000 back halfway from where you bought them, originally. How many shares are there even to buy? 96 million total, not counting those held by the Al Mann Foundation and officers of the company? What is left like 50 million? I mean, you only need about 5000 people to buy 10,000 shares each and then there are no shares left. Then surely the shorts would have to cover. I would think if you guys believe in this company you would just buy them all up. I'll tell you what. If script numbers are good tomorrow I'll buy 10,000 shares. Someone told me that they need to get over 300 total scripts. That sounds awfully low to me, but if they get 300 scripts I'll buy 10,000 shares. Then, maybe, I'll buy another 10,000 every time the scripts go up 100. That should help you guys, right? Who's with me? IF they get 300 sripts, I will see your 10,000 shares and raise you another 10,000 shares. Only IF! |
|
|
|
Post by fanz8967 on Apr 6, 2017 22:20:32 GMT -5
I mean if the shares cost 167,000 and now they are 10,000, you can buy the same amount of shares for another 10,000. If all goes well you'll have 167,000 back halfway from where you bought them, originally. How many shares are there even to buy? 96 million total, not counting those held by the Al Mann Foundation and officers of the company? What is left like 50 million? I mean, you only need about 5000 people to buy 10,000 shares each and then there are no shares left. Then surely the shorts would have to cover. I would think if you guys believe in this company you would just buy them all up. I'll tell you what. If script numbers are good tomorrow I'll buy 10,000 shares. Someone told me that they need to get over 300 total scripts. That sounds awfully low to me, but if they get 300 scripts I'll buy 10,000 shares. Then, maybe, I'll buy another 10,000 every time the scripts go up 100. That should help you guys, right? Who's with me? IF they get 300 sripts, I will see your 10,000 shares and raise you another 10,000 shares. Only IF! See teamwork! |
|
|
|
Post by mango on Apr 6, 2017 22:35:56 GMT -5
For what it's worth, the manipulation we're seeing on the share price post-split is not a new phenomenon. In fact, it's par for the course. The volatile pounding of a company's stock post split is absolute in its intent to shatter the little confidence some long term investors may have (which by the way includes large retail houses). As far as I know, there has been no 'new' negative development that's been announced since the 10K was filed, nor for that matter, since the CC on March 16th - just 16 days ago. What then is causing such activity against the stock price? I don't think this needs any explanation because we all know precisely what is a work here. Mike clearly warned investors 16 days ago that investors should be realistic and not expect any significant spike in prescription numbers for several weeks. In my view, and as far as I'm concerned, that means well into May and please let's not get into a discussion on what the term 'several' means. In addition, the financials and strategy for 2017 were in line with expectations and as I recall more than one analyst and several investors commented on the on progress to date with guarded optimism. Was there lingering trepidation around the company's finances? Yes. That said however, the BOD, CEO and CFO are well aware of upcoming financial obligations and we must trust they are working to fulfill their fiduciary responsibility to all shareholders on this front. Interestingly, since the split, some investors (not here necessarily) speculate that perhaps the split was not the right course rather an extension on the NASDAQ listing should have been pursued. It appears to me that this was not an option. Internal rules which govern such decisions at the exchange may have precluded MannKind from such. Does anyone doubt that if an extension could have been granted, the Board would not have pursued it rather than a reverse split? There is little doubt in my mind though I have NO definitive proof to back up this statement. Some investors have said delisting might have been a better path to take which I ignore completely because clearly these investors forget that MannKind had just hired its own sales force and to delist would have been far more destructive to Mike's re-launch efforts that one can possibly imagine. All employees at MannKind knew full well what a reverse split might do to the value of any options they held. I'm certain they are no more surprized than I am that their value has gone down considerably. What I believe is MannKind's sales reps have fanned out across the country to begin the thankless and laborious task of effecting an unthinkable paradigmn shift, one by one, MD by MD, patient by patient, script by script all the while having to repeatedly dispell half truths left by the sales rep before them. Thankfully thus far I've not seen an exodus of sale reps showing up on the Mannkind's or other Pharma/Biotech jobs boards. They are out there and that's what counts. I think the sales plan and DTC is on track to make the difference Mike has stated we'll see in summer. I am willing to wager my last dollar that by the end of August, the gloom we may be feeling today will be replaced with better spirits. That said, I still ask myself every day despite the erosion of in the value of my investment: 'Am I willing to weather this storm for yet another turbulent day with the same belief and conviction I had when I first learned of Afrezza, what amazing relief it could provide to diabetics and took the leap of faith to invest in the company who developed it?' My answer is always a resounding YES - it most definitely is worth it to me. So I keep my chin up like the proverbial Englishman with bulldog in tow and carry on to the next day. One thing holding scripts back is misinfo and disinfo on numerous diabetes forums online. Believe it or not, there are people who wager that inhaling their insulin is toxic to the lungs, and injecting their amyloidogenic insulin, is safe. I wonder if the same people realize how profoundly misinformed they are. Of course, there are plenty of hawks on these forums that are very quick to dispell anything positive about Afrezza, and conclude that everyone does not mind injections, that they are painless, and so on and so on...kind of like on this forum. Of course, I have already posted the largest diabetic study conducted in the world on injectable insulins that prove majority are non-compliant, reuse their needles, and express fear and pain with their injections (which results in many skipping out on their insulin injections). 🦉 |
|
|
|
Post by boca1girl on Apr 7, 2017 7:15:57 GMT -5
Tinker, I agree with most of what you've said, that's why I bought more post split at $1.70 on 03/28. Nothing materially had changed. However, I've been cut pretty deeply catching the "falling knive" for the last three years.
From all estimates, we run out of cash in July without additional funding. We will make it to August without filling for bankruptcy protection?
Unless Matt is able to delay our loan payments, and/or secures additional debt financing, and/or dilutes with additional share sales, how do we get to August? Product sales will contribute a few dollars but not enough to move the needle. We could receive cash from a foreign distribution partner but we haven't received approvals yet. RLS milestone payments?
Franz suggest we all double down. Nobel concept, but very risky at this juncture.
I believe that Afrezza will be a big success SOME day. Matt has said more than once that he is not going to let Al's Afrezza die, but that doesn't guarantee that current shareholders won't get wiped out along the way. I'm not willing to "wager my last dollar" on MNKD, I've already invested too much to sleep comfortably.
|
|
